Nature Biotechnology, published online: July 22, 2025; DOI: 10.1038 / S41587-025-02752-3
For decades, and in the exceptional case of the Pasteur Institute for more than a century, non -profit organizations have increased R&D to advance scientific understanding and develop affordable and accessible pipelines of vaccines, drugs and diagnostics. Small and medium -sized enterprises and former leaders of the biopharmaceutical industry make a significant contribution to the global health objectives by pursuing opportunities in this corner of the global biopharmaceutical ecosystem.
